Borgmann H, et al. – Researchers developed a comprehensive multi–institutional database which demonstrated that Fuhrman grade is a strong prognostic factor for cancer–specific survival in papillary renal cell carcinoma patients. In addition, patients older than 75 have worse cancer–specific mortality than patients younger than 50 years. These outcomes should be considered for clinical decision making.